and sensitivity); subjects also performed daily nasal nebulization of mometasone and the antibiotic, along with saline pressure hydrotherapy, for a period of 6 weeks. Clinical outcome was assessed using the Lund-Kennedy symptom and endoscopic appearance scores. Biofilm disruption was assessed ex-vivo using the traditional Colony Forming Units (CFUs) bacterial assay technique and semi-quantitative real-time PCR (rt-PCR). Mucosal epithelial barrier changes were evaluated histologically. RESULTS: There was a statistically significant difference in the patients' Lund-Kennedy symptom and endoscopic appearance scores after 6 weeks of rhinotopic therapy. There was also statistically significant difference in CFUs mucosal bacterial count and in microbial and organisms virulence genes presence, indicating mucosal biofilm disruption. Changes indicating mucosal barrier remodeling were observed by H&E histology. Nasoendoscopic-guided cultures performed one month following rhinotopic therapy, showed resolution of the pathogenic organism(s) in 14/23 patients (60.8%). No significant clinical adverse effects were experienced. CONCLUSION: Gel rhinotopic therapy is a promising treatment strategy for refractory chronic rhinosinusitis, and has the potential to cause mucosal biofilm disruption.
Biofilms in Chronic Rhinosinusitis with Nasal Polyps
Thiago Bezerra, MD (presenter); Francini Padua, MD, PhD; Eloisa Gebrim, MD, PhD; Paulo Saldiva, MD, PhD; Richard Voegels, MD, PhD OBJECTIVE: 1) Evaluate the presence of biofilms in patients with chronic sinusitis with nasal polyps. 2) Compare this data with control patients. METHOD: Case-control study conducted between 2008 and 2009, in a tertiary care center. The study group consisted of 33 consecutive patients undergoing endoscopic sinus surgery for chronic rhinosinusitis(CRS) with nasal polyps. The control group consisted of 27 control patients undergoing septoplasty for nasal obstruction without diagnosis of CRS. Preoperative demographic, clinical, quality-of-lifes questionnaire and radiological data were recorded. Mucosal samples were harvested intra-operatively for scanning electron microscopic examination to determine biofilms presence . Statistical analysis was performed. For all statistical tests pϭ0.05 was considered significant. RESULTS: Biofilms were found in 24 (72.7%) of the 33 chronic rhinosinusitis with nasal polyps patients and in 13 (48.1%) of 27 septoplasty patients (Odds ratio ϭ 2.87, CI95% from 0.9796 to 8.419). This difference was not statistically meaningful. CONCLUSION: Its believed that biofilms may play a major role in chronic sinusitis without nasal polyps, not in our study group. Biofilms were demonstrated to be prevalent in patients undergoing sinus surgery for CRS with nasal polyps but also in controls. Although patients with CRS with nasal polyps had more prevalence of biofilms and this difference was not statistically meaningful, data analysis suggests that statistically difference could be found if we increase the sample size. The presence of biofilms on control samples without chronic rhinosinusitis may implies that biofilms may be just colonizers sometimes, and perhaps not the only key for this disease. Other reports may help to elucidate these questions and the role of biofilms in chronic rhinosinusitis with nasal polyps.
C-C Chemokines, RANTES and Eotaxin in Allergic Rhinitis
Shawky Elmorsy, MD (presenter); Asser Sharkawy, MD; Mohamed Elnaggar, MD OBJECTIVE: The objectives of this study were to estimate the levels of Eotaxin, RANTES and tumor necrosing factor-␣ in allergic rhinitis and their relation to disease severity. METHOD: The objectives of this study were to estimate the levels of Eotaxin, RANTES and tumor necrosing factor-␣ in allergic rhinitis and their relation to disease severity.
RESULTS:
The mean values of eotaxin, RANTES, TNF-␣ in severe allergic rhinitis (33.6 11.07 pg/ml, 72.17 87.61 pg/ml, 25.47 4.04 pg/ml) are statistically higher than in mild allergic rhinitis (9.80 6.79 pg/ml, 10.50 6.90 pg/ml, 12.99 3.27 pg/ml), and the mean values of all these parameters were higher in both groups compared to the control group (0.6 0.69 pg/ml, 0.65 0.74 pg/ml, 0.63 0.54 pg/ml). The mean values of eotaxin, RANTES, TNF-␣ in nasal tissue (160.30 51.63 pg/ml, 141.00 55.52 pg/ml, 62.22 7.89 pg/ml) were statistically higher compared to severe (except RANTES), mild allergic rhinitis and control groups. CONCLUSION: This study revealed the roles of local chemokines in the pathogenesis of allergic rhinitis as well as their relation to the severity of the disease which may direct the attention of therapeutic trials to these locally produced chemokines.
Clinical Factors Associated with Bacterial Biofilm Formation
Zi Zhang, MD (presenter); James Palmer, MD OBJECTIVE: Bacterial biofilms appear to contribute to recalcitrant chronic rhinosinusitis (CRS). However, numerous conditions are implicated in the pathogenesis of CRS. The aim of our study is to evaluate clinical factors that associated with bacterial biofilm formation in CRS. METHOD: This is a cross-sectional study continuously enrolled 518 patients with CRS from 2007 to 2009. Samples were taken to evaluate for biofilm formation using a modified Calgary Biofilm Detection Assay. Clinical data were collected and analyzed using Pearson's 2 and multiple logistic regression models.
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